Bioprocessing - Upstream & Downstream

Sitting down with Steve Oh from the Stem Cell Bioprocessing, Bioprocessing Technology Institute, A*STAR

When it comes to cryopreserving cell therapies, there's a right way - and a wrong way…

Five gurus discuss the exciting developments in advanced medicine, and what the field needs to move forward.

Tracing the supply chain back to raw materials and learning how fundamental research is driving advances in cell culture media.

Patheon's Steve Lam shares his lessons learned over three decades in bioprocessing.

Real-time monitoring and analysis of biologics during manufacturing is within reach

The increasing demand for disposable technologies puts pressure on suppliers to up their game

Biopharma manufacturing continues to advance and the demand for new innovations is constant.

Can high density cryopreservation allow biopharma manufacturers to buy back time?

Synthetic biology could help to re-write the rules of biopharma production.